Medicines
SmPC of 12/11/2013
GLYCERIN SUPPOSITORY GIFRER ADULTS, suppository
Composition
Glycerol ........................................................................................................................................................................1,98 g
For a suppository of 3,30 g
Gelatin, purified water.
Indications
- Symptomatic treatment of low constipation, particularly due to rectal dyschezia.
- Preparation for endoscopic examinations of the rectum.
Dosage and administration
- Treatment of lower constipation:
1 to 2 suppositories per day to obtain one bowel movement per day. - Preparation for endoscopic examinations of the rectum:
1 suppository 5 to 30 minutes before the time chosen for evacuation.
Contraindications
History of hypersensitivity to the active substance or to any of the excipients.
Obstructive colopathy, given the laxative effect of the medicine.
Abdominal pain syndrome of undetermined and inflammatory cause (ulcerative colitis, Crohn's disease).
Warnings and precautions
Warnings special
Prolonged use is not recommended.
Drug treatment of constipation is only an adjunct to hygiene and dietary treatment:
- enrichment of the diet with vegetable fibres and fluids,
- Advice on physical activity and rehabilitation of evacuation.
Precautions for use
It is preferable not to use this medicine in cases of colonic disease, hemorrhoidal flare-ups, anal fissures, or hemorrhagic colitis.
Interactions
The data available to date do not suggest the existence of clinically significant interactions.
Fertility, pregnancy and breastfeeding
Use with caution in pregnant or breastfeeding women, due to a lack of usable clinical data.
Adverse effects
Prolonged use may give rise to anal burning sensations and, exceptionally, congestive reactions.
Reporting of suspected adverse reactions
Reporting suspected adverse effects after authorisation of the medicinal product is important. It allows continuous monitoring of the benefit/risk balance of the medicinal product. Health professionals should report any suspected adverse effect via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres. Website: www.ansm.sante.fr.
Overdose
No cases of overdose with glycerol suppositories have been reported. However, in cases of prolonged use, there is an increased risk of proctitis and diarrhoea.
Treatment: discontinuation of treatment or reduction of the dose.
Pharmacodynamics
Pharmacotherapeutic class: LAXATIVE FOR RECTAL USE.
OTHER LAXATIVES (A: Alimentary tract and metabolism) – ATC code: A06AX 01
Glycerin suppositories cause rapid evacuation of the rectosigmoid by triggering the defecation reflex. Defecation occurs within 5 to 30 minutes after administration.
Glycerol stimulates peristaltic movements and decreases water reabsorption through its osmotic and hygroscopic properties. It also has a local irritant effect that contributes to the reflex defecation.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
10 AVENUE DES CANUTS - BP 165
69120 VAULX-EN-VELIN
Tel: 09 70 80 93 39 contact@gifrer.fr
https://www.gifrer.fr/
Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.
